Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pangenomic Health Inc C.NARA

Pangenomic Health Inc. is a precision health company. The Company, through its subsidiaries, is engaged in developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Its products include a mobile app for consumers (Nara), a telehealth mental health app and telehealth platform for consumers (Mindleap) and a clinical decision support... see more

Recent & Breaking News (CSE:NARA)

How Technology Can Be a Game Changer in Mental Health Treatment and AI Is Leading the Way

Newsfile 9 days ago

PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests

Canada NewsWire November 17, 2023

PanGenomic Health Intends to Close Shares for Debt Settlement

Canada NewsWire November 1, 2023

PanGenomic Health Announces Financial Results for Half Year Ended June 30, 2023

Canada NewsWire August 30, 2023

PanGenomic Health Retains Social Media and Data Intelligence Advisory Firm and Announces Shares for Debt Settlement

Canada NewsWire August 9, 2023

PanGenomic Health Announces Director Resignations

Canada NewsWire July 13, 2023

PanGenomic Health Subsidiary Launches Vitamin D Health Assessments and Announces Corporate Appointments

Canada NewsWire July 6, 2023

PanGenomic Health Provides Update for NARA Product and Conversational AI

Canada NewsWire June 6, 2023

PanGenomic Health Signs Non-Binding Letter of intent for an Exclusive Special Purpose Licence of the CyberPatient AI Medical Education Platform

Canada NewsWire May 30, 2023

PanGenomic Health Announces Financial Results for the 2022 Fiscal Year

Canada NewsWire May 2, 2023

PanGenomic Health Announces AGM Results

Canada NewsWire May 2, 2023

PanGenomic Health Subsidiary Signs Master Services Agreement with Psy Integrated and Announces Repricing of Outstanding Warrants

Canada NewsWire April 21, 2023

PanGenomic Health Admitted to Trading on the AQSE Growth Market in London, United Kingdom

Canada NewsWire April 12, 2023

PanGenomic Health Retains UK Investor Relations Advisory Firm

Canada NewsWire April 6, 2023

PanGenomic Health Subsidiary, MUJN Diagnostics, Announces the Engagement of Hemex Health to Assist in the Development of Brain Health Diagnostics System

Canada NewsWire March 30, 2023

PanGenomic Health Announces the Filing of a Business Acquisition Report for Mindleap Health and Provides Update on UK Listing

Canada NewsWire March 28, 2023

Circle Innovation to Support PanGenomic Health Subsidiary, MUJN Diagnostics, with the Development of its Decision Support System

Canada NewsWire March 22, 2023

PanGenomic Health Announces Availability of Women's Hormonal Health DNA Report

Canada NewsWire March 8, 2023

PanGenomic Health Provides Corporate Update

Canada NewsWire March 2, 2023

PanGenomic Health's NARA Debuts New Website, Visual Identity & Natural Wellness E-Commerce Store

Canada NewsWire February 9, 2023